Ciara Linnane
Ciara Linnane
Companies and investing editor, MarketWatch.com. Views my own, obv. Dubliner. Also, I don't own any individual stocks.Source
New York, United States
CRITIC
img-contested
N/A
1 reviews
PUBLIC
img-trusted
100%
5 reviews

RECENT ARTICLES

Sort by:
gold-cheese100%
AMC Theatres launches streaming service in latest blow to Netflix

AMC Theatres launches streaming service in latest blow to Netflix

ShareAMC is the first cinema chain to launch a streaming service, adding to a wave of new competition from Disney, Apple and othersIn the latest blow to Netflix Inc., AMC Theatres, the biggest cinema chain in the world, said Tuesday it is launching a streaming service that will allow members of its loyalty program to rent or buy films and watch them at home, the first such offering from a cinema operator. The 20 million-plus U.S. households that have signed up to the company’s AMC Stubs program will be able to access about 2,000 films from every major studio, starting Tuesday. Later in the...

October 21, 2019
Share
Save
Review
No Rating
Cannabis stocks rally anew as $7 billion GW Pharma deal spurs interest in weed and its medical benefits

Cannabis stocks rally anew as $7 billion GW Pharma deal spurs interest in weed and its medical benefits

Cannabis stocks rallied anew on Wednesday, spurred on by news of a $7 billion deal for the first company to win U.S. regulatory approval for a cannabis-based drug, a move that’s expected to boost investor interest in the plant and its medical benefits. GW Pharmaceuticals Ltd.developer of Epidiolex, the drug that won U.S. Food and Drug Administration approval as a treatment for severe forms of childhood epilepsy in 2018, said earlier it is being acquired by Jazz Pharmaceuticals PLCwhich specializes in sleep medications.The news sent U.S.-listed shares of the U.K.-based GW Pharma up 46% in...

February 3, 2021
Share
Save
Review
No Rating
South Dakota emergency-room nurse says some patients insist COVID-19 isn’t real even as they’re dying from it

South Dakota emergency-room nurse says some patients insist COVID-19 isn’t real even as they’re dying from it

A South Dakota nurse took to Twitter on Sunday to highlight a tragic feature of the coronavirus pandemic: patients who rail against health-care workers because they don’t believe COVID-19 is real.‘The ones who scream at you for a magic medicine and that Joe Biden is going to ruin the USA. All while gasping for breath on 100% Vapotherm. They tell you there must be another reason they are sick. They call you names and ask why you have to wear all that “stuff” because they don’t have COVID because it’s not real.’Jodi Doering, an emergency-room registered nurse, described the phenomenon after...

November 16, 2020
Share
Save
Review
No Rating
Coronavirus tally: Global cases of COVID-19 46.6 million, 1.2 million deaths and Trump hints at firing Fauci

Coronavirus tally: Global cases of COVID-19 46.6 million, 1.2 million deaths and Trump hints at firing Fauci

The global tally for confirmed cases of the coronavirus that causes COVID-19 climbed to 46.6 million on Monday, according to , while the death toll rose to 1.2 million. The U.S. has the highest case total at 9.2 million and deaths at 231,003. Dr. Anthony Fauci, America's foremost infectious-disease expert and the director of the National Institute of Allergy and Infectious Diseases, that the U.S. is "in for a whole lot of hurt," during the winter months with cases spiking across the nation. Fauci added that the U.S. needs to make an "abrupt change" in public health practices and behaviors...

November 2, 2020
Share
Save
Review
No Rating
Coronavirus update: U.S. death toll tops 225,000 and Trump’s chief of staff says U.S. is ‘not going to control the pandemic’

Coronavirus update: U.S. death toll tops 225,000 and Trump’s chief of staff says U.S. is ‘not going to control the pandemic’

The U.S. death toll from the coronavirus illness COVID-19 rose above 225,000 on Monday, with more than 20 states reaching record levels of new infections, and President Donald Trump’s chief of staff said the U.S. is “not going to control the pandemic.” Mark Meadows, said the U.S. would not be able to control the spread, “because it is a contagious virus just like the flu.”The White House would instead “control the fact that we get vaccines, therapeutics and other mitigation areas.” Vaccine makers have said they do not expect to have a vaccine ready for regulatory scrutiny any time soon, as...

October 26, 2020
Share
Save
Review
No Rating
Coronavirus update: CDC says nearly 300,000 excess American deaths have occurred during pandemic

Coronavirus update: CDC says nearly 300,000 excess American deaths have occurred during pandemic

The U.S. death toll from the coronavirus illness COVID-19 rose above 221,000 on Wednesday, as the nation’s leading public health agency said almost 300,000 Americans have died during the pandemic, including fatalities that would not have happened without the virus. In the Centers for Disease Control and Prevention said the number is higher because it includes people who died from heart attacks or other medical emergencies that were untreated because people were afraid to go to a hospital.The study also uncovered that the biggest percentage rise in excess deaths were in those aged 25 to 44,...

October 21, 2020
Share
Save
Review
No Rating
Cloud company Snowflake raises IPO price range to $100 to $110 vs. prior $75 to $85

Cloud company Snowflake raises IPO price range to $100 to $110 vs. prior $75 to $85

Cloud company Snowflake Inc.raised the proposed price range for its initial public offering on Monday to $100 to $110, up from a prior $75 to $85. The company is planning to offer 28 million shares to raise up to $3.08 billion. The company has applied to list on the New York Stock Exchange under the ticker 'SNOW.' There are 23 banks underwriting the deal led by Goldman Sachs and Morgan Stanley. Proceeds will be used for general corporate purposes, including potential acquisitions. "We believe in a data connected world where organizations have seamless access to explore, share, and unlock...

September 14, 2020
Share
Save
Review
No Rating
UPDATE: Short seller Hindenburg alleges that electric truck maker Nikola is an 'intricate fraud' in new report

UPDATE: Short seller Hindenburg alleges that electric truck maker Nikola is an 'intricate fraud' in new report

Short seller Hindenburg Research published a report on electric truck maker Nikola Inc.on Thursday, accusing it of being built on lies told by its Founder and Executive Chairman Trevor Milton over many years. Nikola shares fell 9% on the news. "We have gathered extensive evidence-including recorded phone calls, text messages, private emails and behind-the-scenes photographs-detailing dozens of false statements by Nikola Founder Trevor Milton," said the report. "We have never seen this level of deception at a public company, especially of this size." Nikola has misled partners by making...

September 10, 2020
Share
Save
Review
No Rating
New York Gov. Cuomo says President Trump has put politics above public health throughout pandemic

New York Gov. Cuomo says President Trump has put politics above public health throughout pandemic

New York Gov. Andrew Cuomo issued a scathing critique of President Donald Trump’s handling of the coronavirus pandemic on Monday, saying he has denied the reality of the situation from Day 1:‘He said it doesn’t exist, it’s going to go away, by Easter we’ll be reopened, it’s going to go away like a miracle. It didn’t go away, there was no miracle — he denied reality.’“The federal government,” Cuomo said at a press briefing, “is committing gross negligence.”A key factor, according to Cuomo, is that Trump is putting a political agenda over public health policy.“It’s politically inconvenient in...

July 13, 2020
Share
Save
Review
No Rating
‘Don’t smoke the Kool-Aid,’ analyst says in sober note on the cannabis sector

‘Don’t smoke the Kool-Aid,’ analyst says in sober note on the cannabis sector

MKM analyst Bill Kirk slaps sell ratings on Curaleaf and Aurora Cannabis, but says Acreage Holdings and Hexo are a buyMKM Partners initiated coverage of five Canadian cannabis companies and two U.S. multi-state operators on Friday with a cautious outlook, arguing that the current business model of cultivation will become commoditized and make it difficult for companies to build strong brands. In a note entitled, “Don’t Smoke the Kool-Aid,” analyst Bill Kirk, an executive director at MKM, said supply will likely exceed consumer spending growth, which will pressure existing business models....

September 22, 2019
Share
Save
Review
  • Total 14 items
  • 1
  • 2
OUTLETS
marketwatch.com

marketwatch.com

CRITIC
img-contested
N/A
PUBLIC
img-trusted
90%